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Background: Most trials on the reliability of constant-load treadmill testing use one pair of treadmill settings (speed,
grade) only. The question of whether the results can be applied to tests with different settings is left open. Also,
claudication distances measured with differing settings are not comparable, rendering the comparison of the results from
different trials difficult. This study evaluates the reliability of constant-load testing with various workloads and compares
them with claudication distances achieved with walking at normal speed on level ground but also evaluates whether
metabolic equivalent (MET) normalization can be used to translate the results of different treadmill tests into each other.
Methods: Fifteen patients with claudication underwent repeated treadmill testing with different treadmill settings,
including speeds of 2.0, 3.2, and 4.0 km/h (1.25, 2.0, and 2.5 mph, respectively) and grades of 0% and 12%. The walking
capacity was also tested on level ground with a speed chosen by the individual patient. Results of virtual treadmill tests
with all possible combinations of the speeds and the grades used were predicted from real tests, with MET normalization.
The relationship between real and predicted claudication distances was tested with regression modeling.
Results: Reliability coefficients (RCs) for the absolute claudication distance (ACD) were superior to RCs for the initial
claudication distance. RCs for ACD ranged between 0.61 and 0.95, with increasing values found with increasing
workloads. The best coefficients for the regression of measured on predicted claudication distances were achieved with a
model on the basis of a power function (r  0.963). The model was only appropriate for the prediction of group mean
results from clinical trials but cannot be applied to single patient data. For proof of concept, the model was tested with
six published studies in which the claudication distances of a patient sample were double treadmill tested with different
workloads. The result of the second test was predicted from the first test, and estimated and measured claudication
distances were compared. The mean difference (all trials) was 7.9%, whereas the maximum difference amounted to 16.5%.
Conclusion: For an optimal treadmill test reliability, higher workloads should be used and ACD should be preferred over
initial claudication distance. MET normalization provides the basis for the comparability of treadmill test results achieved
with different test conditions. (J Vasc Surg 2002;36:83-8.)
Two treadmill protocols, a graded-load test (fixed
speed, progressively increasing grade) and a constant-load
(C-test; fixed speed and grade), have been developed to test
the impairment of the functional capacity in patients with
intermittent claudication. Although both protocols are
used internationally and although both have been shown to
be of similar reliability,1 European investigators historically
tend to favor the constant-load protocol. However, no
clear agreement exists on what treadmill settings (speed and
grade) shall be given preference, with the consequence that
a wide range of settings (with speeds as low as 2 km/h
[1.25 mph] and grades as steep as 15%) is used in clinical
trials. One difficulty with this situation is that with different
settings the claudication distances of the same patient sam-
ple will vary with lower results occurring at a higher work-
load. This renders the comparison of the results of different
clinical trials, which apply different treadmill settings, diffi-
cult.
A number of studies confirmed that C-tests are charac-
terized with a high reliability.1-6 However, most of these
trials used a speed of 3.2 km/h (2 mph) with grades
between 10% and 12% and did not provide any information
on the C-test reliability with different treadmill settings.
Thus, the aim of this study was to describe the treadmill
reliability and reproducibility with five different constant-
load treadmill protocols and to develop a methodology that
would allow for a comparison of claudication distances
achieved with different workloads.
METHODS
Patient sample. Fifteen patients with peripheral artery
disease (PAD), with intermittent claudication (claudication
pain at calf level) with subjective claudication distances
between 100 and 1000 m (approximately 300 to 3000 ft),
underwent multiple treadmill testing. A heterogeneous
patient sample was used, representative of patients who may
be entered into a clinical trial on the treatment of intermit-
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tent claudication, and thus a wide range of claudication
distances was accepted for inclusion to avoid any bias
regarding conclusions on treadmill test reliability and test
result predictability.
The diagnosis of PAD was established through patient
history and physical examination and confirmed with
Doppler scan assessment of ankle/brachial pressure indices,
which ought to be 0.9 or less at rest. Intermittent claudi-
cation had to be present for 6 months or more, with clinical
stability given for 3 months or more. All patients had to be
able to walk on a treadmill with no concomitant disease
present, which might interfere with treadmill testing. Pa-
tients with a peripheral polyneuropathy and patients who
underwent vascular reconstruction during a 6-month pe-
riod before this trial were excluded. No patient was on
vasoactive drugs for the treatment of PAD. The demo-
graphic data of the patient sample are summarized in Table
I.
Claudication distance testing. The study protocol
foresaw five constant-load treadmill tests to be performed
within a 3-week period of time, with speeds of 2.0 km/h
(1.25 mph), 3.2 km/h (2 mph), and 4.0 km/h (2.5 mph)
and grades of 0% and 12% used with each speed (the 2.0
km/h [1.25 mph] protocol was only performed with a 12%
grade). Also, the claudication distances of all patients were
tested at level ground (hospital floor), with a walking speed
considered normal by the individual patient. All claudica-
tion distances were assessed twice, leading to a total num-
ber of 12 tests per patient (10 treadmill tests, two walking
tests with individual speed). The sequence of these 12 tests
was randomized. All patients had treadmill tests before the
trial; thus, all patients were guaranteed familiar with the test
methodology. Handrail support was allowed only for brief
moments to maintain balance. Treadmill testing was dis-
continued if the absolute claudication distance (ACD) was
not reached within 30 minutes. The chosen cut-off of 30
minutes may seem long; however, 30 minutes at 2 km/h
(1.25 mph) correspond to 1000 meters (approximately
3000 ft), a claudication distance that may occur in a clinical
trial setting, particularly after treatment, and that must be
testable with sufficient reliability.
Outcome measures. The primary endpoints of this
study were the initial claudication distance (ICD) and the
ACD. ICD was defined as the distance walked to the point
of the onset of the claudication symptoms, and ACD was
the maximal distance walked to the point where severe
claudication pain forced the cessation of exercise.
Hemodynamic assessment. The ankle/arm pressure
index of the reference leg (ABI) and the heart rate were
assessed before each treadmill test and were reassessed 1
minute after ACD was reached. Also, the total pressure
recovery time was recorded through repeated measure-
ments in 2-minute intervals.
Calculation of treadmill test–related energy expen-
diture. To estimate the rate of energy expenditure during
steady state treadmill testing, metabolic equivalents
(METs) were calculated. One MET equals the oxygen
consumption at rest (VO2), which is approximately 3.5 mL
kg1 min1. To calculate whole body work-related energy
expenditure, the VO2 of three components must be con-
sidered with treadmill testing: horizontal, vertical, and rest-
ing. Following the Guidelines for Exercise Testing and
Prescription of the American College of Sports Medicine
(ACSM),7 the O2 cost of horizontal walking is 0.1 mL
kg1 min1 per m min1 of horizontal velocity, whereas
the O2 cost of vertical work equals 1.8 mL kg
1 min1.
Because patients do not walk up a vertical treadmill, the
actual vertical work performed is thus estimated with mul-
tiplication of the O2 cost of vertical work with treadmill
grade and velocity. The total VO2 estimate equals the sum
of the three VO2 components. Units of VO2 were finally
converted into METs. A prerequisite for the formula of the
ACSM is a linear relationship between treadmill workload
and VO2, not only in healthy subjects but also in patients
with PAD; that this condition is met is shown in the
literature.8,9
Hypothesis: mathematic prediction of claudication
distances. That the ratio of the results from two treadmill
tests, which used different workloads for testing, is corre-
lated to the ratio of the METs, characteristic for the two
treadmill protocols, was hypothesized. If this relationship
would exist, the result of a virtual treadmill test could be
approximated from the result of a real test, which was
performed with a higher or a lower workload. The predic-
tion would be on the basis of the equation: CDpredicted 
CDmeasured  METmeasured  METpredicted
1, where CD-
predicted is the predicted claudication distance, CDmeasured is
the result of the real treadmill test, METmeasured is the MET
for the real treadmill test, and METpredicted is the MET
describing the treadmill setting for the predicted test.
Table I. Demographics of patient sample
Characteristics
No. of patients 15
Gender
Male/female 10/5
Age (years)
Mean  SD 69.4  9.1
Range 49-81
Weight (kg)
Mean  SD 74.4  11.0
Range 57.8-88.8
BMI (kg/cm2)
Mean  SD 26.6  3.68
Range 20.5-32.6
Risk factors
Hypertension 11
Diabetes mellitus 5
Hyperlipidemia 8
Smoking
Current 9
Non current 5
Duration of PAD (years)
History 6
Range 1-20
Mean ABI at rest  SD 0.55  0.08
SD, Standard deviation; BMI, body mass index; ABI, ankle/arm pressure
index.
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Proof of hypothesis. To prove the hypothesis, the
following sequence of steps was considered appropriate: 1,
documentation of ICDs and ACDs as measured with vary-
ing test conditions; 2, calculation of the ratios of claudica-
tion distances, which were measured with different testing
conditions (claudication distance converting factors ratio
of two claudication distances, measured with different test-
ing conditions); 3, calculation of the ratios of MET values
characteristic for the two testing conditions used with point
2 (MET-converting factors  ratio of two MET values
characteristic for two treadmill test conditions); 4, perfor-
mance of a correlation analysis for claudication distance–
converting factors and MET-converting factors; and 5,
prediction of all possible results of virtual treadmill tests
from each of the measured treadmill results. Regression
modeling was used to test the relationship between both
sets of data (measured, predicted).
Statistics. For the description of the treadmill test
reliability, reliability coefficients (RCs), also known as in-
traclass correlation coefficients, and coefficients of variation
(CV) were used.10 RC is defined as the ratio of the be-
tween-subject variance (2B) and the total variance (
2
T),
which is calculated as the sum of 2B and the process-
related variance (2W): RC  (
2
B)  (
2
W  
2
B)
1.
For the evaluation of the relationship between mea-
sured and calculated claudication distances, analyses of
covariance were used. Also, measures of constant and pro-
portional bias were calculated. For correlation analyses,
Spearman correlation coefficients are reported. Measured
claudication distances were compared with the Wilcoxon
signed rank test. The probability limit for significantly
rejecting the null hypothesis was set to .05 (5%). The
statistical analysis was performed with the statistical package
StatView 5.0 (SAS Institute Inc, Cary, NC).
Ethical and legal aspects. The study protocol was
reviewed and approved by the Institutional Review Board
of the University of Basel Medical School (Ethisches
Komittee beider Basel). Written informed consent was
obtained from all patients before enrolment.
RESULTS
Claudication distances
As shown in Table II, ICDs and ACDs decreased with
increasing workload, that is increasing speed or grade or
both. Workload may also be described in terms of METs.
METs and claudication distances were closely correlated
with correlation coefficients for ICD and ACD of r 
0.98 and r  0.96, respectively. In comparison of the
results from the two tests performed with identical work-
load, the claudication distances were not significantly dif-
ferent from each other; this statement applies to all tread-
mill protocols.
Walking on level ground with individual speed
When patients were requested to choose their individ-
ual speed for walking on level ground, the speed selected
was fast and reproducible (ie, 4.03  0.48 km/h and
4.06 0.50 km/h for the first and the second test, respec-
tively [2.52  0.3 mph and 2.54  0.31 mph]). These
walking speeds translate into an energy expenditure of
2.92 0.23 MET and 2.93 0.24 MET (  2.93 0.23
MET). Results are summarized in the lower part of Table
II.
Reliability of treadmill protocols
Table III lists RCs and CVs for ICD and ACD for all
test conditions. RCs for ICD range between 0.71 and 0.83
with no clear relationship between RCs and treadmill test
workload; the corresponding CVs range between 13.2%
and 26.0%. In contrast, RCs and CVs for ACD range
between 0.61 and 0.95 and 9.4% and 19.9%, with increas-
Table II. Claudication distances (ICD, ACD) from repeated tests and mean values from various treadmill protocols
Settings MET ICD test 1 ICD test 2 Mean ICD ACD test 1 ACD test 2 Mean ACD
3.2 km/h; 0% 2.5 187  121 150  77 171  104 405  219 417  267 411  239
4 km/h; 0% 2.9 160  75 150  55 155  65 315  114 319  131 317  121
2.0 km/h; 12% 4.0 136  61 129  47 131  58 250  109 255  119 252  112
3.2 km/h; 12% 5.8 102  46 108  43 105  44 204  116 200  81 202  98
4 km/h; 12% 7.0 102  37 100  36 101  36 167  80 171  81 169  79
Individual speed; 0% 2.9 156  53 166  65 161  58 376  137 368  108 372  121
Table III. RC and CV with various treadmill protocols for ICD and ACD
3.2 km/h; 0% 4.0 km/h; 0% 2.0 km/h; 12% 3.2 km/h; 12% 4.0 km/h; 12%
Individual speed;
0%
2.5 MET 2.9 MET 4.0 MET 5.8 MET 7.0 MET 2.93 MET
RC CV RC CV RC CV RC CV RC CV RC CV
ICD 0.817 26.0% 0.828 13.8% 0.792 17.2% 0.713 19.3% 0.833 13.2% 0.789 13.4%
ACD 0.614 19.9% 0.835 11.5% 0.843 13.1% 0.855 12.4% 0.952 9.7% 0.873 9.6%
JOURNAL OF VASCULAR SURGERY
Volume 36, Number 1 Degischer et al 85
ing reliability with increasing workload (rRC  0.892;
rCV 0.777). RCs and CVs for ACD were numerically but
not statistically superior to the respective values for ICD.
To evaluate whether the variance occurring with re-
peated treadmill testing was dependent on hemodynamic
characteristics of the patient sample, an analysis of covari-
ance was performed with the categorized postexercise pres-
sure drop, the postexercise ABI drop, and the categorized
pressure recovery time as independent variables. However,
none of the covariates did explain the variance of the
treadmill test results.
Mathematic prediction of treadmill results on basis of
metabolic equivalent normalization
General. Correlation analyses were performed to
study the relationship between claudication distance–
converting factors and MET-converting factors (correla-
tion analyses were justified because scattergrams of the two
variables gave no evidence of a nonlinear relationship). The
correlation coefficient for ICD–converting factors and
MET–converting factors was r  0.800; the respective
value for ACD was r  0.982 (P  .001, each).
Prediction on basis of mean results from study
sample. Results of virtual treadmill tests were predicted
from the measured treadmill results of the study sample.
Regression modeling was used to test the relation between
both sets of data (measured, predicted). With a linear
model, the regression coefficients for ICD data and ACD
data were r  0.884 and r  0.943, respectively. An
exponential model resulted in r values of 0.911 (ICD) and
0.953 (ACD); a power function numerically improved the
curve fit and yielded regression coefficients of r  0.923
(ICD) and r  0.963 (ACD).
Prediction on basis of single patient data. Results of
virtual treadmill tests were predicted from each of the
measured individual treadmill results. Regression modeling
was used to test the relation between both sets of data
(measured, predicted). The relation between measured and
predicted claudication distances was shown with a regres-
sion coefficient of r  0.660. With an exponential model,
the coefficient numerically improved (r 0.718), and with
a power function, the coefficient increased to r  0.802.
Logarithmic transformation of data together with a linear
regression model, or application of polynominal regression
models, did not further improve the curve fitting.
Application of model on published data (proof of
concept). A Medline search was performed for papers that
reported results from double treadmill testing a patient
sample with different treadmill workloads; the treadmill
speed had to exceed 2.0 km/h. Six trials were veri-
fied.6,11-15 The mean value of the claudication distance of
the patient sample resulting from the first treadmill test was
used as the basis for the prediction of the result of the
second treadmill test and vice versa. Table IV summarizes
the results and provides a comparison of the predicted and
the measured claudication distances. The mean differences
between all measured and predicted claudication distances
were 7.9% and 8.0%. The maximum difference between
measured and predicted results amounted to 14.1% and
16.5%, respectively.
DISCUSSION
The primary findings of this study include that, for a
high C-test reliability, ACD rather than ICD should be
selected as the endpoint and that a higher workload should
be preferred. The study also provides strong evidence that
MET normalization is an appropriate measure for the ap-
proximation of the magnitude of a virtual treadmill test
result, of any high workload real test result available.
Treadmill test reliability. If RCs of more than 0.8 are
considered acceptable to reflect an appropriate level of
reliability, then all workloads used for ACD testing except
2.5 MET fulfil this demand. However, RCs increase with
increasing workload, yielding constant-load treadmill test-
ing with 5.8 or more MET more reliable than with other
settings. The reliability results achieved for ICD were less
Table IV. Comparison of predicted and measured treadmill results
Paper
reference
no. n
Speed km/h
(grade) of
first test
Speed km/h
(grade) of
sec. test
ACD
first test
(m)
ACD
second test
(m)
Predicted
ACD second
test (m) Difference
Difference
23 1*
11 18 4.0 (0.0) 4.0 (8.0%) 135 270 273 1.2% 1.2%
12 30 5.0 (5.2%) 5.0 (10.5%) 146 183 205 10.8% 12.1%
30 5.0 (5.2%) 5.0 (10.5%) 248 311 348 10.7% 12.0%
30 5.0 (5.2%) 5.0 (10.5%) 337 441 473 6.8% 7.3%
6 10 3.0 (0.0) 4.0 (0.0) 287 390 343 13.9% 12.2%
13 12 3.2 (12.5%) 3.2 (25.0%) 179 118 114 3.8% 3.9%
12 3.2 (0.0) 3.2 (12.5%) 400 179 170 5.4% 5.7%
12 3.2 (0.0) 3.2 (25.0%) 400 118 108 8.9% 9.8%
12 3.2 (12.5%) 4.4 (12.5%) 185 153 141 7.9% 8.6%
14 6 3.0 (3.5%) 3.0 (7.0%) 250 169 197 16.5% 14.1%
16 11 3.0 (3.5%) 3.0 (7.0%) 297 236 234 0.9% 0.9%
X  7.88 X  7.98
Measured data from published literature; see also text.
*Difference between measured and predicted claudication distance when the result of test 1 was predicted of test 2 (detailed data not given in this Table).
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convincing. Although most of the RCs exceeded 0.8, there
is no clear pattern, with RCs of 0.71 even occurring at high
workload. From this, ACD may be concluded as the end-
point preferred over ICD. Some literature, including our
own previous work, did show that ICD and ACD were
comparably reproducible2-6 and that the use of ACD was
mandatory for graded-load protocols only.1 However, these
trials used one pair of treadmill settings only; also, the discrep-
ancy between the cited literature and this study’s results clearly
shows that a sufficient reliability is not guaranteed with ICD as
the endpoint.
After the results of this study, there is good reason to
favor higher workloads. However, higher workloads were
previously shown to be problematic for testing patients
with short claudication distances because the between-
subject variance component may drop, no longer allowing
for the separation of different short claudication distances.1
Thus, a compromise regarding the workload is necessary,
which should warrant an acceptably high reproducibility in
patients with longer claudication distances but which
should still allow for the testing of short claudication dis-
tances. This compromise may be in the order of magnitude
of 5 to 6 METs.
Mathematic prediction of treadmill test results.
From a theoretic point of view, the easiest way to become
independent of treadmill settings and to guarantee the
comparability of results from different trials would be to
mathematically calculate cumulative work, rather than to
use the claudication time as the endpoint. This model may,
however, be too simple and may not reflect the true phys-
iologic situation. For better agreement with exercise phys-
iology, METs were used to describe treadmill work-
load.7,16 The prerequisite for any mathematic prediction of
treadmill test results would be the proof of an appropriate
correlation of claudication distance conversion factors and
the conversion factors for the respective METs. That this
relation exists for the group mean results was shown in this
paper. Thus, the prediction of the mean claudication dis-
tance of the entire study sample, which would result from
testing with different workloads, seems to be feasible. The
regression coefficients that described the relationship be-
tween measured and predicted claudication distances were
r 0.943 for ACD and r 0.884 for ICD; at least the value
for ACD is thought to be in an order of magnitude, which
may be considered appropriate for the purpose of prediction.
With application of the model to published data (patient
samples tested with different workloads),6,11-15 the estimates
were astonishingly similar to the measured results. This “put-
ting the model on test” does not replace a proper prospective
validation but does provide evidence on its appropriateness.
In contrast, the results of treadmill test predictions for
individual patients were problematic. If each of the claudi-
cation distances were taken as the basis to predict the
outcome of all treadmill test protocols used in this study,
the regression coefficient for a linear regression model was
as low as r  0.660. If a power function was used instead,
the regression coefficient rose to r  0.802. These coeffi-
cients show the relation between the variables, but the level
of this relationship is insufficient for an accurate prediction.
The explanation for this finding may be related to the
problem of accurately estimating exercise-related VO2 and
MET values. Although VO2 (and thus MET) estimates for
walking are relatively accurate for most speeds and grades,
speeds of less than 3.0 km/h (1.9 mph) may lead to a
substantial underestimation, particularly for level ground
walking. The degree of underestimation for VO2 with these
conditions may exceed 20%,7 reflecting a situation as shown
in this study’s data. Also, the estimation of the VO2 from
constants derived from healthy subjects,7 as used in this
study, may be generally problematic in patients with PAD
because the patients may be forced by the claudication pain
to stop exercise before reaching a steady state; the latter,
however, is a prerequisite for the O2 consumption con-
stants as published by the ACSM. In addition, patients with
PAD, particularly those with short claudication distances
and long-standing disease, have lost the ability to walk
economically. The exercise-related O2 cost in these patients
may more resemble that of jogging or high-speed walking
than that of level or grade walking of healthy subjects or
patients with PAD with milder disease. In this situation, the
O2 cost of horizontal exercise may double
7; the vertical
component may also be problematic to calculate. When a
healthy person would walk up small grades quickly, some of
the vertical lift normally found in fast level walking would
be used to accomplish grade work, thus reducing the O2
cost of grade work. This argument may no longer apply for
severely limited, untrained, unphysiologically and uneco-
nomically walking patients with PAD, rendering the esti-
mation of the O2 cost of vertical exercise difficult.
Claudication distance testing on level ground with
individual walking speed. When the results of an inter-
vention in patients with PAD is described with treadmill
tested changes in the claudication distances, these changes
cannot be easily transformed into the changes the patient
would have with daily life conditions. With the assumption
that the energy expenditure for walking a certain distance at
home is less than walking the same distance on a treadmill
(difference in grade and speed), it is generally accepted that
the effect of an intervention will be more pronounced with
daily life conditions than when tested on a treadmill.17
After this study’s results, this basic assumption is not
necessarily correct. Because the average individually chosen
walking speed was approximately 4.0 km/h (2.5 mph), and
thus somewhat higher than expected from reports in the
literature (3.0 to 3.9 km/h),18 the mean energy expendi-
ture translated into approximately 2.9 MET. In compari-
son of the results of a 2.9-MET treadmill test with the
results of the “individual test,” the mean claudication dis-
tance values were in good agreement. It is not known to
what extent this study’s results may be “center or Swiss
specific” and to what extent one may extrapolate from it.
Patient groups from other geographic areas may be used to
slower speeds and a higher interpatient speed variation.
Still, when the estimation of a change in walking ability
with daily life conditions is an issue, as it always will be when
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considering the clinical relevance of the results of a medical
intervention,19 it may be suggested to design a trial in a way
that claudication distances are assessed on the treadmill (ac-
cording to the trial protocol) but that the patients normal
walking speed (eg, on a hospital floor) is also documented.
This simple extra measure will allow calculation of the average
energy expenditure and prediction of the daily life walking
ability of treadmill tested changes in the claudication distances
with some degree of reliability. However, the lower the mean
walking speed for the study sample will be, the more relevant
will be the argumentation on the limits of the MET calcula-
tion and the higher will be the error for the estimate.
Limitations of the study. The major limitation of this
study is that only two grades and three speeds were used for
treadmill testing. The inclusion of further settings would
have substantially improved the conclusiveness of this trial.
However, the total number of tests per patient was 12, a
number that was considered maximum by the Ethics Com-
mittee for practical and for risk reasons. With 12 treadmill
tests performed during a 3-week period, training effects
might potentially have occurred. However, because the
claudication distances from the two tests performed with
equal settings were not statistically different from each
other with either of the five treadmill protocols, minor
training effects cannot be excluded, but these were limited
enough to be neglected. Also, any training effect would
have led to a deterioration but never to an improvement of
the reliability results reported in this paper.
CONCLUSION
To guarantee an appropriate test reliability with re-
peated constant-load treadmill testing, a higher workload
should be chosen and ACD should be used as the endpoint.
Because C-testing with a high workload is inappropriate for
the assessment of short claudication distances, a workload
in the limits of approximately 5.0 to 6.0 MET may be
recommended as a compromise.
With the help of MET normalization, the results of
different clinical trials, with different workloads for claudi-
cation distance testing, become better comparable.
Whereas the technique is appropriate for application to the
mean results of larger patient samples, it cannot be used on
an individual patient basis.
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